Pacific Biosciences Of California | PACB - Ebitda



金融业
股票价格
USD
资产
USD 782.37M
现金及等价物
USD 56.27M
销售成本
USD 28.9M
流动资产
USD 369.52M
流动负债
USD 65.36M
债务
USD 892.24M
股息收益率
0
EBIT
USD -53.19M
EBITDA
USD -35.4M
员工
796
EPS每股收益
USD -0.17
股本和储备
USD 2.37M
销售毛利
USD 15.74M
债务利息支出
USD 1.74M
贷款资金
USD 645.38M
市值
USD 444.8M
净收入
USD -40.37M
营业费用
USD 97.83M
营业利润
USD -53.19M
普通股股本
USD 301.96M
税前利润
USD -40.17M
销售收入
USD 44.65M
销售和管理费用
USD 37.24M
股票
USD 51.02M
贸易债权人
USD 13.61M
应收帐款人
USD 35.45M


Ebitda 更改 日
Agilent USD 456M 84M 2025-12
Bruker USD 110M 101.6M 2026-03
Danaher USD 1.92B 204M 2026-03
General Electric Aerospace USD 2.84B 568M 2026-03
Illumina USD 469M 137M 2025-12
Myriad Genetics USD 14.3M 4M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quidel USD 108.7M 44.6M 2026-03
Revvity USD 272.91M 24M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Standard Biotools USD -8.01M 7.8M 2026-03
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Waters USD 380.97M 85.83M 2025-12